2022 Q3 Form 10-Q Financial Statement

#000168316822007192 Filed on November 01, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $38.66K $39.00 $30.12K
YoY Change
Operating Profit -$38.66K -$39.00 -$30.12K
YoY Change
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $0.00
YoY Change
Pretax Income -$38.66K -$39.00 -$30.12K
YoY Change
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$38.66K -$20.04K -$10.12K
YoY Change 244.61% 1944.44%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 71.85B shares 71.85M shares 71.85M shares
Diluted Shares Outstanding 71.85B shares 71.85M shares 71.85M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $92.20K $0.00 $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables $238.0K
Total Short-Term Assets $330.2K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $330.2K
Total Long-Term Assets $0.00
Total Assets $330.2K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $663.8K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $663.8K
Total Long-Term Liabilities
Total Liabilities $1.666M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$73.91M
YoY Change
Common Stock $72.57M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.336M -$1.298M -$1.278M
YoY Change
Total Liabilities & Shareholders Equity $330.2K
YoY Change

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$38.66K -$20.04K -$10.12K
YoY Change 244.61% 1944.44%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$120.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $120.00
YoY Change
NET CHANGE
Cash From Operating Activities -$120.00
Cash From Investing Activities $0.00
Cash From Financing Activities $120.00
Net Change In Cash $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$120.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei City Area Code
CityAreaCode
408
dei Local Phone Number
LocalPhoneNumber
533-8155
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
71850033691 shares
CY2022Q3 us-gaap Cash
Cash
92195 usd
CY2021Q4 us-gaap Cash
Cash
0 usd
CY2022Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
238000 usd
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
0 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
330195 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
0 usd
CY2022Q3 us-gaap Assets
Assets
330195 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
usd
CY2022Q3 AFTC Common Shares Issued For Preferred Stock Converted
CommonSharesIssuedForPreferredStockConverted
usd
AFTC Acquisition Disposal Of Intangible Assets
AcquisitionDisposalOfIntangibleAssets
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
AFTC Common Shares Issued For Preferred Stock Converted
CommonSharesIssuedForPreferredStockConverted
usd
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
CY2021Q4 us-gaap Assets
Assets
0 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
18250 usd
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Central Index Key
EntityCentralIndexKey
0001182731
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity File Number
EntityFileNumber
000-26113
dei Entity Registrant Name
EntityRegistrantName
CONNEXIONONE CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NC
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
30-1252905
dei Entity Address Address Line1
EntityAddressAddressLine1
39899 BALENTINE DRIVE
dei Entity Address Address Line2
EntityAddressAddressLine2
SUITE 200
dei Entity Address City Or Town
EntityAddressCityOrTown
NEWARK
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94560
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9500 usd
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
645555 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
255296 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
663805 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
264796 usd
CY2022Q3 us-gaap Other Liabilities
OtherLiabilities
1002639 usd
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
1002639 usd
CY2022Q3 us-gaap Liabilities
Liabilities
1666444 usd
CY2021Q4 us-gaap Liabilities
Liabilities
1267435 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000000 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71850033691 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71850033691 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71846033691 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71846033691 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
71850034 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
71846034 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
721152 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
-274848 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73907435 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73838621 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-1336249 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1267435 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
330195 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2022Q3 us-gaap Revenues
Revenues
0 usd
CY2021Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
28750 usd
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
0 usd
us-gaap Professional Fees
ProfessionalFees
58750 usd
us-gaap Professional Fees
ProfessionalFees
4500 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9905 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
0 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10064 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1810 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
38655 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
0 usd
us-gaap Operating Expenses
OperatingExpenses
68814 usd
us-gaap Operating Expenses
OperatingExpenses
6310 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-38655 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
0 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-68814 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6310 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
-0 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
-0 usd
us-gaap Interest Expense
InterestExpense
-0 usd
us-gaap Interest Expense
InterestExpense
-0 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-0 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-0 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-38655 usd
us-gaap Profit Loss
ProfitLoss
-68814 usd
us-gaap Profit Loss
ProfitLoss
-6310 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-38655 usd
us-gaap Net Income Loss
NetIncomeLoss
-68814 usd
us-gaap Net Income Loss
NetIncomeLoss
-6310 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-38655 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
0 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-68814 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6310 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71847033691 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71846033691 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71846370687 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71846033691 shares
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.000
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71847033691 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71846033691 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71846370687 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71846033691 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1261076 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-495 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1261571 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-5815 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1267386 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-1267386 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1267435 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-10120 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1277555 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-20039 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1297594 usd
CY2022Q3 AFTC Common Shares Issued For Preferred Stock Converted Shares
CommonSharesIssuedForPreferredStockConvertedShares
-1000000 shares
CY2022Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4000000 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-38655 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-1336249 usd
us-gaap Net Income Loss
NetIncomeLoss
-68814 usd
us-gaap Net Income Loss
NetIncomeLoss
-6310 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
8750 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-160 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-60064 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6470 usd
AFTC Acquisition Disposal Of Intangible Assets
AcquisitionDisposalOfIntangibleAssets
238000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-238000 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
390259 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-143975 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
390259 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-143975 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
92195 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-150445 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
150445 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
92195 usd
AFTC Common Shares Issued For Preferred Stock Converted
CommonSharesIssuedForPreferredStockConverted
1000000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_zk7iTVNNqfDk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_866_zWGuGPktyOX3">Use of estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s significant estimates include income taxes provision and valuation allowance of deferred tax assets; the fair value of financial instruments; the carrying value and recoverability of long-lived assets, including the values assigned to an estimated useful lives of computer equipment; and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management regularly reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2022Q3 us-gaap Other Liabilities
OtherLiabilities
1002639 usd
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
1002639 usd
CY2022Q3 us-gaap Other Liabilities
OtherLiabilities
1002639 usd
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
1002639 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73907435 usd
CY2022Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
238000 usd
CY2022Q3 AFTC Liabilities Carryover From Prior Abandoned Operations
LiabilitiesCarryoverFromPriorAbandonedOperations
665735 usd
CY2021Q4 AFTC Liabilities Carryover From Prior Abandoned Operations
LiabilitiesCarryoverFromPriorAbandonedOperations
665735 usd
CY2022Q3 AFTC Accrual Carryover From Prior Abandoned Operations
AccrualCarryoverFromPriorAbandonedOperations
336904 usd
CY2021Q4 AFTC Accrual Carryover From Prior Abandoned Operations
AccrualCarryoverFromPriorAbandonedOperations
336904 usd
CY2022Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
645555 usd
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
255296 usd
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71850033691 shares
CY2022Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
one-for-one thousand (1:1,000) reverse stock split
CY2022Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
73907435 usd

Files In Submission

Name View Source Status
0001683168-22-007192-index-headers.html Edgar Link pending
0001683168-22-007192-index.html Edgar Link pending
0001683168-22-007192.txt Edgar Link pending
0001683168-22-007192-xbrl.zip Edgar Link pending
aftc-20220930.xsd Edgar Link pending
connexionone_10q-093022.htm Edgar Link pending
connexionone_ex3101.htm Edgar Link pending
connexionone_ex3102.htm Edgar Link pending
connexionone_ex3201.htm Edgar Link pending
connexionone_ex3202.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
aftc-20220930_cal.xml Edgar Link unprocessable
Show.js Edgar Link pending
aftc-20220930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
aftc-20220930_lab.xml Edgar Link unprocessable
aftc-20220930_pre.xml Edgar Link unprocessable
connexionone_10q-093022_htm.xml Edgar Link completed